Edward N. Libby
University of San Diego(US)University of Washington(US)Fred Hutch Cancer Center(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → Diagnosis and Management of Multiple Myeloma(2022)922 cited
- → Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study(2019)777 cited
- → Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis(2021)622 cited
- → Global Burden of Multiple Myeloma(2018)610 cited
- → Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma(2022)443 cited
- → A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study(2020)438 cited